COSMOS Pharmaceutical Corporation (3349.T)

9053.0035.00 (-0.39%)

COSMOS Pharmaceutical Corporation (3349.T) stock comprehensive ESG Analysis including ESG score, ESG rating, ESG trends, ESG performance, ESG metrics. Compare ESG against peers/competitors, industry and sector standards.

Low Bankruptcy RiskLow ProfitabilityEfficient OperationsModerate GrowthModerate QualityAdequate Dividend ProfileIndustry Rank: 67.57%Sector Rank: 75.68%

JPX - Healthcare - Medical - Pharmaceuticals | Market Cap: 717.52B | Next Earnings Date: 14 Oct 2025

Day's Range

8935.00 - 9125.00

52-Week Range

6347.00 - 10045.00

Volume

380.0K / 335.9K (Avg.)

P/E Ratio | EPS

23.15 | 391.09

Trending:

3349.T ESG Analysis

Evaluation Basis

Value Investing Sector Medians Industry Medians

Compare against a Competitor

None

Gauges a company's environmental, social, and governance practices.

ESG Score

No Data

No Data available this quarter, please select a different quarter.

Environmental Score

No Data

No Data available this quarter, please select a different quarter.

Social Score

No Data

No Data available this quarter, please select a different quarter.

Governance Score

No Data

No Data available this quarter, please select a different quarter.

3349.T ESG Analysis

Evaluation Basis

Value Investing Sector Medians Industry Medians

Compare against a Competitor

None

Gauges a company's environmental, social, and governance practices.

ESG Score

No Data

No Data available this quarter, please select a different quarter.

Environmental Score

No Data

No Data available this quarter, please select a different quarter.

Social Score

No Data

No Data available this quarter, please select a different quarter.

Governance Score

No Data

No Data available this quarter, please select a different quarter.